Detalhe da pesquisa
1.
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.
Lancet
; 401(10373): 281-293, 2023 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36566761
2.
Consultations for clinical features of possible cancer and associated urgent referrals before and during the COVID-19 pandemic: an observational cohort study from English primary care.
Br J Cancer
; 126(6): 948-956, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34934176
3.
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
Lancet
; 398(10303): 843-855, 2021 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34388395
4.
Correction to: Use of prescribing safety quality improvement reports in UK general practices: a qualitative assessment.
BMC Health Serv Res
; 21(1): 539, 2021 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34078359
5.
d-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial.
JAMA Intern Med
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587819
6.
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes.
J Infect
; 88(4): 106130, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38431155
7.
Postpandemic Sentinel Surveillance of Respiratory Diseases in the Context of the World Health Organization Mosaic Framework: Protocol for a Development and Evaluation Study Involving the English Primary Care Network 2023-2024.
JMIR Public Health Surveill
; 10: e52047, 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38569175
8.
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients.
Nat Commun
; 15(1): 1652, 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38396069
9.
Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease.
BMJ Open
; 13(8): e069176, 2023 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37550022
10.
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
Lancet Respir Med
; 9(9): 1010-1020, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34329624
11.
Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk.
BMJ Open
; 11(6): e046799, 2021 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34145016
12.
Evaluation of a Simple Low-cost Intervention to Empower People with CKD to Reduce Their Dietary Salt Intake: OxCKD1, a Multicenter Randomized Controlled Trial.
Kidney360
; 4(7): 890-898, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37254243
13.
Cell selective glucocorticoid induction of caveolin-1 and caveolae in differentiating pulmonary alveolar epithelial cell cultures.
Biochem Biophys Res Commun
; 359(2): 360-6, 2007 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-17537407